Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …

Haploidentical donors are now increasingly considered for transplantation in the absence of
HLA-matched donors or when an urgent transplant is needed. Donor-specific anti-HLA …

Clinical application of umbilical cord blood (UCB) as a source of hematopoietic stem cells for
transplantation is limited by low CD34+ cell dose, increased risk of graft failure, and slow …

Aplastic anemia, an unusual hematologic disease, is the paradigm of the human bone
marrow failure syndromes. Almost universally fatal just a few decades ago, aplastic anemia …

Background Umbilical-cord blood has been used as the source of hematopoietic stem cells
in an estimated 30,000 transplants. The limited number of hematopoietic cells in a single …

The potential benefits of unrelated donor marrow transplantation are offset by the
immunologic complications of graft-versus-host disease (GVHD) and infection. Therefore …

Background Data regarding the outcome of cord-blood transplantation in adults are scant,
despite the fact that these grafts are increasingly used in adults. Methods We compared the …

Effectiveness of double umbilical cord blood (dUCB) grafts relative to conventional marrow
and mobilized peripheral blood from related and unrelated donors has yet to be established …

Background Although umbilical cord blood is an accepted alternative to bone marrow for
transplantation, allele-matched bone marrow is generally regarded as the preferred graft …

Background Promising results of cord-blood transplants from unrelated donors have been
reported in adults. Methods We compared outcomes in 682 adults with acute leukemia who …